Drug-loaded contact lenses for glaucoma treatment appear to demonstrate safety and effectiveness in reducing IOP, according to a systematic review published in European Journal of Pharmacology. Drug-l ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

topical eye drops containing Cys would be a better therapy for preventing the development of dry eye with cGVHD. Therefore, appropriate timing and institution of immunosuppressive drugs may limit ...

Topical prophylaxis alone is inadequate for these ... Avoid contaminating the applicator tip with material from the eye, fingers, or other source. Two year oral studies conducted in rats with ...

Patients may be subject to a variety of different topical medications when undergoing ... to treat diseases such as glaucoma and dry eye syndrome, has been linked to irritation, dryness and ...

Futura Medical's development of a topical treatment for erectile dysfunction ... and also avoids the potential side effects of oral drugs for ED, which can take 30-60 minutes to take effect.

In November, the U.S. FDA declined to approve reproxalap, Aldeyra’s (ALDX) lead asset, for dry eye disease ... it would resubmit a new drug application for the topical therapy in H2 2024 ...

Betaliq is developing a global portfolio of topical glaucoma treatments based on the unique ... while using less total drug. EyeSol ® based eye drops are non-preserved not containing any chemical ...

The study on topical cyclosporine contained calculation errors affecting its conclusions. Authors requested a temporary retraction to review and correct inaccuracies. Ensuring data integrity is ...

a second drug candidate in preclinical development—INM-088, a CBN-based topical eye drop formulation for the treatment of glaucoma; and additional discovery programs utilizing CBN and other rare ...